Off Patent
April 2027

Amyvid

florbetapir F-18

Avid Radiopharmaceuticals Inc

Solution (intravenous) · NDA 202008

Last listed protection ends
April 30, 2027

The FDA lists 2 patents for Amyvid, and this is the day the last one ends. It is not the date a generic goes on sale.

Patents and exclusivities

  1. Patent 7,687,052
    Claims the drug substance, the drug product and a use (U-4217)
  2. Patent 8,506,929
    Claims the drug substance, the drug product and a use (U-4217)